Diaceutics was launched in 2005 by a trio of partners with significant experience in developing and successfully commercializing both drugs and diagnostic tests, with the purpose of providing an operational structure and process for pharmaceutical drug development teams to successfully commercialize personalized medicine products.

Having accomplished that early goal, and with the continued rapid evolution of the personalized medicine space and increasing demand from their clients, Diaceutics began looking at ways to make their approach and process scalable. To accomplish that goal, Diaceutics has built a catalog of personalized medicine specific software applications that allow pharmaceutical companies to fully internalize the knowledge and operational process developed by Diaceutics, and to begin to build a corporate memory in the personalized medicine space.

 
Tiffany Olson, BSc MBA
Chairwoman of the Board
Peter Keeling, BA MA
Chief Executive Officer
Patrick Considine, PhD
Chief Scientific Officer
 
Mollie Roth, JD
Chief Operating Officer
Tom Zietlow, PhD, MBA
President
Christof Koelsch, MD, PhD
Senior Vice President, Strategy & Innovation
 
Les Kondejewski, PhD
Director
Sanna Paakkonen, MSc
Director
Ryan Keeling, MEng
Senior Vice President, IT Solutions
 
Patrick Farnan, MEng
Software Architect